These scientific publications are authored or co-authored by CDC scientists and/or funded by CDC’s Global Immunization Division, Center for Global Health. 2022 Assessing the impact of the routine childhood hepatitis B immunization program and the need for hepatitis B vaccine birth dose in Sierra Leone, 2018. Breakwell L, Marke D, […]
An update from the CDC’s Advisory Committee on Immunization Practices (ACIP) is intended to boost low hepatitis B vaccination rates and decrease disease cases among adults aged 19 to 59 years. James Cavallini/sciencesource.com Instead of screening this age group for vaccination based on risk factors such as injection drug use, having multiple […]
The European Medicines Agency’s (EMA’s) human medicines committee has recommended approval of a hepatitis B vaccine for adults. The agency’s Committee for Medicinal Products for Human Use (CHMP) granted a positive opinion for PreHevbri on February 24 for active immunization against hepatitis B virus (HBV) infection. PreHevbri (PreHevBrio in the United States and Sci-B-Vac […]
